(ATAT) Atour Lifestyle Holdings - Overview
Stock: Hotel Management, Retail Services, Property Services, Travel Agency
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.20% |
| Yield on Cost 5y | 6.38% |
| Yield CAGR 5y | 128.04% |
| Payout Consistency | 100.0% |
| Payout Ratio | 9.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Relative Tail Risk | -4.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.03 |
| Alpha | 38.83 |
| Character TTM | |
|---|---|
| Beta | 0.561 |
| Beta Downside | 0.793 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.26% |
| CAGR/Max DD | 0.35 |
Description: ATAT Atour Lifestyle Holdings January 08, 2026
Atour Lifestyle Holdings Ltd. (NASDAQ: ATAT) is a Shanghai-based operator that builds and manages lifestyle-oriented hotel brands across mainland China. Through its subsidiaries it delivers day-to-day hotel management, sells ancillary hotel supplies, and extends services into retail, investment, property, technology, and travel-agency operations. The firm was incorporated in 2012 and now functions primarily as a franchisee-service platform for Chinese hotel owners.
Key industry metrics that shape Atour’s outlook include: (1) China’s domestic hotel occupancy, which the China Hospitality Association reported at ~71 % in Q3 2024-well above the 58 % pre-pandemic average, indicating strong demand recovery; (2) average daily rate (ADR) growth of roughly 9 % YoY in the upscale segment, driven by rising consumer spending and relaxed travel restrictions; and (3) the rapid adoption of integrated property-tech solutions, with the Chinese market expected to invest > CNY 200 billion in hotel-tech platforms through 2026, a trend that could enhance Atour’s ancillary software services. These drivers suggest a favorable tailwind for revenue expansion, but the company’s exposure to regulatory shifts in the hospitality sector and the competitive pressure from large domestic chains remain material risks.
For a deeper, data-driven assessment of ATAT’s valuation and risk profile, you may find ValueRay’s analytical tools useful for independent research.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -1.70 > 1.0 |
| NWC/Revenue: 40.24% < 20% (prev 37.62%; Δ 2.62% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.97b > Net Income 1.47b |
| Net Debt (-1.03b) to EBITDA (2.17b): -0.47 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (140.1m) vs 12m ago 0.91% < -2% |
| Gross Margin: 43.86% > 18% (prev 0.40%; Δ 4347 % > 0.5%) |
| Asset Turnover: 112.7% > 50% (prev 92.24%; Δ 20.41% > 0%) |
| Interest Coverage Ratio: 812.4 > 6 (EBITDA TTM 2.17b / Interest Expense TTM 2.60m) |
Altman Z'' 5.60
| A: 0.41 (Total Current Assets 6.83b - Total Current Liabilities 3.17b) / Total Assets 8.95b |
| B: 0.23 (Retained Earnings 2.07b / Total Assets 8.95b) |
| C: 0.26 (EBIT TTM 2.11b / Avg Total Assets 8.08b) |
| D: 0.39 (Book Value of Equity 2.04b / Total Liabilities 5.26b) |
| Altman-Z'' Score: 5.60 = AAA |
Beneish M -2.88
| DSRI: 1.13 (Receivables 458.3m/297.0m, Revenue 9.10b/6.65b) |
| GMI: 0.90 (GM 43.86% / 39.52%) |
| AQI: 0.87 (AQ_t 0.05 / AQ_t-1 0.06) |
| SGI: 1.37 (Revenue 9.10b / 6.65b) |
| TATA: -0.06 (NI 1.47b - CFO 1.97b) / TA 8.95b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of ATAT shares?
Over the past week, the price has changed by +7.93%, over one month by -0.76%, over three months by -3.02% and over the past year by +44.14%.
Is ATAT a buy, sell or hold?
- StrongBuy: 12
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ATAT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.8 | 24% |
| Analysts Target Price | 48.8 | 24% |
| ValueRay Target Price | 43.6 | 10.8% |
ATAT Fundamental Data Overview February 07, 2026
P/E Trailing = 24.125
P/E Forward = 20.0401
P/S = 0.5577
P/B = 9.0438
Revenue TTM = 9.10b CNY
EBIT TTM = 2.11b CNY
EBITDA TTM = 2.17b CNY
Long Term Debt = 2.00m CNY (from longTermDebt, last quarter)
Short Term Debt = 348.0m CNY (from shortTermDebt, last quarter)
Debt = 1.64b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.03b CNY (from netDebt column, last quarter)
Enterprise Value = 31.07b CNY (35.16b + Debt 1.64b - CCE 5.74b)
Interest Coverage Ratio = 812.4 (Ebit TTM 2.11b / Interest Expense TTM 2.60m)
EV/FCF = 16.37x (Enterprise Value 31.07b / FCF TTM 1.90b)
FCF Yield = 6.11% (FCF TTM 1.90b / Enterprise Value 31.07b)
FCF Margin = 20.85% (FCF TTM 1.90b / Revenue TTM 9.10b)
Net Margin = 16.19% (Net Income TTM 1.47b / Revenue TTM 9.10b)
Gross Margin = 43.86% ((Revenue TTM 9.10b - Cost of Revenue TTM 5.11b) / Revenue TTM)
Gross Margin QoQ = 43.32% (prev 45.30%)
Tobins Q-Ratio = 3.47 (Enterprise Value 31.07b / Total Assets 8.95b)
Interest Expense / Debt = 0.03% (Interest Expense 477.0k / Debt 1.64b)
Taxrate = 29.79% (201.6m / 676.7m)
NOPAT = 1.48b (EBIT 2.11b * (1 - 29.79%))
Current Ratio = 2.16 (Total Current Assets 6.83b / Total Current Liabilities 3.17b)
Debt / Equity = 0.44 (Debt 1.64b / totalStockholderEquity, last quarter 3.70b)
Debt / EBITDA = -0.47 (Net Debt -1.03b / EBITDA 2.17b)
Debt / FCF = -0.54 (Net Debt -1.03b / FCF TTM 1.90b)
Total Stockholder Equity = 3.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.23% (Net Income 1.47b / Total Assets 8.95b)
RoE = 44.50% (Net Income TTM 1.47b / Total Stockholder Equity 3.31b)
RoCE = 63.73% (EBIT 2.11b / Capital Employed (Equity 3.31b + L.T.Debt 2.00m))
RoIC = 43.88% (NOPAT 1.48b / Invested Capital 3.38b)
WACC = 7.62% (E(35.16b)/V(36.80b) * Re(7.98%) + D(1.64b)/V(36.80b) * Rd(0.03%) * (1-Tc(0.30)))
Discount Rate = 7.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.51%
[DCF Debug] Terminal Value 82.49% ; FCFF base≈1.80b ; Y1≈2.22b ; Y5≈3.78b
Fair Price DCF = 617.3 (EV 69.11b - Net Debt -1.03b = Equity 70.14b / Shares 113.6m; r=7.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 64.11 | EPS CAGR: 107.2% | SUE: 2.88 | # QB: 1
Revenue Correlation: 96.04 | Revenue CAGR: 49.03% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.10 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=14.89 | Chg30d=-0.059 | Revisions Net=+6 | Growth EPS=+24.9% | Growth Revenue=+23.5%